The Neuroimaging Core will continue to provide support for all neuroimaging studies performed on AD and related dementias by ADRC and ADRC-associated investigators. The Core builds on its successes with the development and distribution of methodologies for acquisition and interpretation of a comprehensive functional magnetic resonance imaging (MRI) protocol at 3.0 Tesla and to extend services to encompass positron emission tomography (PET). Procedures for acquiring, archiving and managing all the clinical MR imaging examinations performed on patients referred for ADRC evaluation are in place. Ready access to fMRI technology for paradigm design and image analysis continues to encourage new investigators and novel approaches into AD research. Based on current results from the Core, such fMRI studies offer new insight into innate brain responses to disease and subsequent dysfunction. Such functional parameters may prove useful clinically. As PET remains a focus of activity within the ADRC and uses MRI resources, support for this modality has also been encompassed into the Core. This expanded role should serve to foster efficient use of combined imaging modalities and facilitate communication between investigators using these resources. Through interactions with other research grants, the expanded Core faculty enable greater access to a broader scope of support and expertise without substantial increase in cost.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005133-18
Application #
6448150
Study Section
Project Start
2001-05-01
Project End
2002-03-31
Budget Start
Budget End
Support Year
18
Fiscal Year
2001
Total Cost
$158,272
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Lopez, Oscar L; Becker, James T; Chang, YueFang et al. (2018) Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality. Neurology 90:e1920-e1928
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Zhao, Yujing; Tudorascu, Dana L; Lopez, Oscar L et al. (2018) Amyloid ? Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia. JAMA Neurol 75:88-96
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Irimata, Katherine E; Dugger, Brittany N; Wilson, Jeffrey R (2018) Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes. Curr Alzheimer Res 15:1032-1044
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872

Showing the most recent 10 out of 667 publications